Fredun Pharma
FREDUN • Pharmaceuticals & Biotechnology
Last Price
₹1477.70
Market Cap
₹2.42K Cr
Sector
Pharmaceuticals & Biotechnology
For educational/research use only. Not a recommendation to buy or sell.
At a glance
as of 2026-10-16Sector: Fredun Pharma (FREDUN) is an NSE-listed company in the Pharmaceuticals & Biotechnology sector, within the Pharmaceuticals industry. NSE sector rotation chart
Sharia rating: Fredun Pharma is rated Not halal by a specialist third-party provider. Full list of halal NSE stocks
Price trend
No reading
We don't have enough data to measure this for Fredun Pharma right now.
Institutional activity
Neutral
Trading patterns over recent weeks show no clear sign of institutions buying or selling Fredun Pharma (buying score 2/10, selling score 2/10).
Model rank
Positive
Our model's 5-day return score puts Fredun Pharma ahead of 75% of NSE stocks. The model is only moderately confident (50%).
Ease of trading
Low
Shares change hands easily; there are no signs of trading drying up (risk score 0/10).
Price vs profits
Well above typical
The share price is 78× last year's profit per share — well above the typical range for NSE stocks (15–30×).
The wider Indian market is in a crisis regime — unusually sharp moves (model 99% sure). This affects every stock's model rank.
Browse ready-made screens →Company Information
About Fredun Pharma (FREDUN)
Fredun Pharma is an NSE-listed company operating in the Pharmaceuticals & Biotechnology sector, within the Pharmaceuticals industry (ISIN INE194R01017). This page brings together the quantitative research signals our models compute for FREDUN: a model-estimated 1-day, 5-day and 21-day return outlook, momentum and trend indicators, institutional-activity context derived from observed trading flows, a snapshot of valuation and quality fundamentals, and the instrument's Sharia-compliance status. All figures are produced by statistical models from historical data and are intended for research and educational purposes.
To read the page, treat the model-estimated return outlook as a relative ranking signal rather than a forecast of price — higher scores reflect stronger model-estimated momentum and trend alignment, not a target or guarantee. The momentum and trend indicators describe how Fredun Pharma's recent price action compares with its own history, while the fundamentals and institutional-activity context add longer-horizon and flow-based perspective. Nothing here is investment advice, a recommendation, or a solicitation to transact; always do your own research and consult a SEBI-registered adviser before making any decision.
The "typical range" we compare a price-to-earnings multiple against is a fixed band for all NSE stocks, not a sector-specific one. Everything on this page describes what our models measured; none of it is a recommendation to do anything.